BEONE MEDICINES (06160) releases its performance for the first three quarters, with a net profit attributable to the parent company of 1.139 billion yuan, turning a loss into a profit year-on-year.

BEONE MEDICINES (06160) released its performance for the first three quarters of 2025, with the group achieving operating income of RMB 27.595 billion, a year-on-year increase of 44.2%; net profit attributable to shareholders of the listed company was RMB 1.139 billion, turning from a loss to a profit year-on-year; basic earnings per share were RMB 0.81.